Cargando…

Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database

The implications of the recent change in the definition of pulmonary hypertension on epidemiology and outcomes are not known. We sought to determine the percentage of patients with the two most common lung diseases that would be reclassified regarding the presence/absence of pulmonary hypertension w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nathan, Steven D., Barnett, Scott D., King, Christopher S., Provencher, Steeve, Barbera, Joan A., Pastre, Jean, Shlobin, Oksana A., Seeger, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020109/ https://www.ncbi.nlm.nih.gov/pubmed/33868639 http://dx.doi.org/10.1177/2045894021999960

Ejemplares similares

Pulmonary hypertension in chronic lung disease and hypoxia
por: Nathan, Steven D., et al.
Publicado: (2019)

Does 1-minute walk test predict results of 6-minute walk test in patients with idiopathic pulmonary fibrosis?
por: Nunes, Flavia S., et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes
por: Pastre, Jean, et al.
Publicado: (2021)

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis
por: Chandel, Abhimanyu, et al.
Publicado: (2023)

Extracorporeal Membrane Oxygenation as a Bridge to Initial Medical Therapy in a Patient With Decompensated Pulmonary Arterial Hypertension Presenting With Biventricular Failure
por: Mabe, Donovan, et al.
Publicado: (2019)

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
por: Chandel, Abhimanyu, et al.
Publicado: (2021)

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
por: Lajoie, Annie-Christine, et al.
Publicado: (2017)

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

The cancer theory of pulmonary arterial hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2011)

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis
por: Thomas, Christopher, et al.
Publicado: (2023)

Definition and Management of Segmental Pulmonary Hypertension
por: Dimopoulos, Konstantinos, et al.
Publicado: (2018)

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
por: Lajoie, Annie C., et al.
Publicado: (2018)

Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2015)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013)

Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020)

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2020)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary Hypertension
por: Piccari, Lucilla, et al.
Publicado: (2023)

Pulmonary hypertension associated with COPD
por: Naeije, Robert, et al.
Publicado: (2001)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
por: Lemay, Sarah-Eve, et al.
Publicado: (2021)

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2020)

Pulmonary hypertension and chronic lung disease: where are we headed?
por: Elia, Davide, et al.
Publicado: (2019)

COVID-19 and the pulmonary vasculature
por: Provencher, Steeve, et al.
Publicado: (2020)

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension
por: Malenfant, Simon, et al.
Publicado: (2017)

Mechanics and mechanisms of pulmonary hypertension—Conference summary and translational perspectives
por: Seeger, Werner, et al.
Publicado: (2013)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis
por: Guay, Charles-Antoine, et al.
Publicado: (2018)

Systematic review of validated case definitions to identify hypertensive disorders of pregnancy in administrative healthcare databases
por: Johnston, Amy, et al.
Publicado: (2023)

Near-fatal haemoptysis as presentation of a giant intralobar pulmonary sequestration
por: Ferland, Nancy, et al.
Publicado: (2015)

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022)

Sharing and Reusing Computable Phenotype Definitions
por: Visweswaran, Shyam, et al.
Publicado: (2023)

Updated definition of exercise pulmonary hypertension
por: Zeder, Katarina, et al.
Publicado: (2022)

Dual ET(A)/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
por: Nadeau, Valerie, et al.
Publicado: (2017)

Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study
por: Sahay, Sandeep, et al.
Publicado: (2020)

Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis
por: Chandel, Abhimanyu, et al.
Publicado: (2023)

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
por: Chelladurai, Prakash, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3akj3i7c6dk2lt5b8e0pde10ig